FACULTY OF HEALTH AND MEDICAL SCIENCES UNIVERSITY OF COPENHAGEN The 3rd Porcine Biomedical Models meeting 23 October 2014 “Pig models for diabetes late complications” Venue: Faculty of Medical and Health Sciences, University of Copenhagen Frederiksberg Campus, Grønnegårdsvej 7, auditorium A1-04.01 (the old auditorium 2-01 in the anatomy building), 1870 Frederiksberg C. Registration, coffee and lunch will be in the old Zoology collection at first floor. Open Meeting: No registration fee Please register to Helle Lohmann Schøler [email protected] before 8 October 2014 The 3rd Porcine Biomedical Models meeting: Pig models for diabetes late complications Programme Thursday 23 October 2014 Pig models for diabetes late complications 9.00-9.30: Registration and coffee 9.30-9.35: Welcome 9.35- 10.20: Prof. Robert Wilensky, University of Pennsylvania Health System, USA: Studies on the diabetic and hypercholesterolemic pig 10.20-10.30: Discussion 10.30-11.00: Coffee 11.00-11.45: Prof. Robert Wilensky, University of Pennsylvania Health System, USA: New insights in acute coronary syndromes derived from intracoronary imaging 11.45-12: Discussion 12.00-13.00: Lunch 13.00-13.45: Dr. Laura Maile, Director Research and Development, Vascular Pharmaceuticals Inc, USA: Porcine models of diabetic nephropathy 13.45-14.00: Discussion 14.00-14.30: Coffee 14.30-15.00: Assistant Prof. Yonglun Luo, Department of Biomedicine, Aarhus University (previous Novo Nordisk STAR postdoc fellow): The HIP pig: a humanized minipig model of amyloidosis-associated diabetes 15.00-15.15: MSc student Liv von Voss Blom, University of Copenhagen/Technical University of Denmark/Novo Nordisk A/S: Preliminary findings: Vascular gene expression in a diet induced atherosclerotic minipig model 15.15-15.30: Late breaking news from porcine biomedical research 15.30-16.00: Discussion and final remarks Open Meeting: Registration to Helle Lohmann Schøler [email protected] before 8 October 2014 Organizers: Prof. Lisbeth Høier Olsen, University of Copenhagen, Prof. Peter Heegaard, Technical University of Denmark & Principal Scientist Berit Ø. Christoffersen, Novo Nordisk A/S. 2